Top

Published in:

01-01-2019 | Topic Paper

Update of the ICUD–SIU International Consultation on Bladder Cancer 2018: urinary diversion

Authors: Oscar Rodríguez Faba, Mark D. Tyson, Walter Artibani, Bernard H. Bochner, Fiona Burkhard, Scott M. Gilbert, Tilman Kälble, Stephan Madersbacher, Roland Seiler, Ella C. Skinner, George Thalmann, Joachim Thüroff, Peter Wiklund, Richard Hautmann, Joan Palou

Published in: World Journal of Urology | Issue 1/2019

Abstract

Purpose

To provide a comprehensive overview and update of the joint consultation of the International Consultation on Urological Diseases (ICUD) and Société Internationale d’Urologie on Bladder Cancer Urinary Diversion (UD).

Methods

A detailed analysis of the literature was conducted reporting on the different modalities of UD. For this updated publication, an exhaustive search was conducted in PubMed for recent relevant papers published between October 2013 and August 2018. Via this search, a total of 438 references were identified and 52 of them were finally eligible for analysis. An international, multidisciplinary expert committee evaluated and graded the data according to the Oxford System of Evidence-based Medicine.

Results

The incidence of early complications has been reported retrospectively in the range of 20–57%. Unfortunately, only a few randomized controlled studies exist within the field of UD. Consequently, almost all studies used in this report are of level 3–4 evidence including expert opinion based on “first principles” research.

Conclusions

Complications rates overall following RC and UD are significant, and when strict reporting criteria are incorporated, they are much higher than previously published. Complications can occur up to 20 years after surgery, emphasizing the need for lifelong follow-up. Progress has been made to prevent complications implementing robotic surgery and fast track protocols. Preoperative patient information, patient selection, surgical techniques, and careful postoperative follow-up are the cornerstones to achieve good results.

Hautmann RE, Abol-Enein H, Lee CT et al (2015) Urinary diversion: how experts divert. Urology 85:233–238CrossRefPubMed

Philips B, Ball C, Sackett D et al (2009) Oxford centre for evidence-based medicine—levels of evidence (March 2009). http://www.cebm.net/oxford-centre-evidence-based-medicine-levels-evidence-march-2009/

Kalble T, Tricker AR, Friedl P et al (1990) Ureterosigmoidostomy: long-term results, risk of carcinoma and etiological factors for carcinogenesis. J Urol 144:1110–1114CrossRefPubMed

Kalble T, Hofmann I, Riedmiller H et al (2011) Tumor growth in urinary diversion: a multicenter analysis. Eur Urol 60:1081–1086CrossRefPubMed

Ravi R, Dewan AK, Pandey KK (1994) Transverse colon conduit urinary diversion in patients treated with very high dose pelvic irradiation. Br J Urol 73:51–54CrossRefPubMed

Fontenot PA Jr, Barnes BD, Parker WP et al (2018) Postoperative outcomes after radical cystectomy in patients with prior pelvic radiation. Urology 116:131–136CrossRefPubMed

Shabsigh A, Korets R, Vora KC et al (2009) Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology. Eur Urol 55:164–174CrossRefPubMed

Ballas L, Sargos P, Orre M et al (2017) Tolerance of orthotopic ileal neobladders to radiotherapy: a multi-institutional retrospective study. Clin Genitourin Cancer 15:711–716CrossRefPubMed

Eswara JR, Efstathiou JA, Heney NM et al (2012) Complications and long-term results of salvage cystectomy after failed bladder sparing therapy for muscle invasive bladder cancer. J Urol 187:463–468CrossRefPubMed

10.

Volkmer BG, Gschwend JE, Herkommer K et al (2004) Cystectomy and orthotopic ileal neobladder: the impact on female sexuality. J Urol 172:2353–2357CrossRefPubMed

11.

Kehlet H (1997) Multimodal approach to control postoperative pathophysiology and rehabilitation. Br J Anaesth 78:606–617CrossRef

12.

Tyson MD, Chang SS (2016) Enhanced recovery pathways versus standard care after cystectomy: a meta-analysis of the effect on perioperative outcomes. Eur Urol 70:995–1003CrossRefPubMedPubMedCentral

13.

Cerruto MA, D’Elia C, Siracusano S et al (2016) Systematic review and meta-analysis of non RCT’s on health related quality of life after radical cystectomy using validated questionnaires: better results with orthotopic neobladder versus ileal conduit. Eur J Surg Oncol 42:343–360CrossRefPubMed

14.

Yang LS, Shan BL, Shan LL et al (2016) A systematic review and meta-analysis of quality of life outcomes after radical cystectomy for bladder cancer. Surg Oncol 25:281–297CrossRefPubMed

15.

Gacci M, Saleh O, Cai T et al (2013) Quality of life in women undergoing urinary diversion for bladder cancer: results of a multicenter study among long-term disease-free survivors. Health Qual Life Outcomes 11:43CrossRefPubMedPubMedCentral

16.

Mansson A, Davidsson T, Hunt S et al (2002) The quality of life in men after radical cystectomy with a continent cutaneous diversion or orthotopic bladder substitution: is there a difference? BJU Int 90:386–390CrossRefPubMed

17.

Lee RK, Abol-Enein H, Artibani W et al (2014) Urinary diversion after radical cystectomy for bladder cancer: options, patient selection, and outcomes. BJU Int 113:11–23CrossRefPubMed

18.

Somani BK, Gimlin D, Fayers P et al (2009) Quality of life and body image for bladder cancer patients undergoing radical cystectomy and urinary diversion—a prospective cohort study with a systematic review of literature. Urology 74:1138–1143CrossRefPubMed

19.

Mattei A, Birkhaeuser FD, Baermann C et al (2008) To stent or not to stent perioperatively the ureteroileal anastomosis of ileal orthotopic bladder substitutes and ileal conduits? Results of a prospective randomized trial. J Urol 179:582–586CrossRefPubMed

20.

Yong SM, Dublin N, Pickard R et al (2003) Urinary diversion and bladder reconstruction/replacement using intestinal segments for intractable incontinence or following cystectomy. Cochrane Database Syst Rev 2:CD003306

21.

Madersbacher S, Schmidt J, Eberle JM et al (2003) Long-term outcome of ileal conduit diversion. J Urol 169:985–990CrossRefPubMed

22.

Nieuwenhuijzen JA, de Vries RR, Bex A et al (2008) Urinary diversions after cystectomy: the association of clinical factors, complications and functional results of four different diversions. Eur Urol 53:834–842 (discussion 842–834) CrossRefPubMed

23.

Burkhard FC, Kessler TM, Springer J et al (2006) Early and late urodynamic assessment of ileal orthotopic bladder substitutes combined with an afferent tubular segment. J Urol 175:2155–2160 (discussion 2160–2151) CrossRefPubMed

24.

Waingankar N, Mallin K, Smaldone M et al (2017) Assessing the relative influence of hospital and surgeon volume on short-term mortality after radical cystectomy. BJU Int 120:239–245CrossRefPubMed

25.

Hautmann RE, de Petriconi RC, Volkmer BG (2011) 25 years of experience with 1,000 neobladders: long-term complications. J Urol 185:2207–2212CrossRefPubMed

26.

Studer UE, Danuser H, Thalmann GN et al (1996) Antireflux nipples or afferent tubular segments in 70 patients with ileal low pressure bladder substitutes: long-term results of a prospective randomized trial. J Urol 156:1913–1917CrossRefPubMed

27.

Gross T, Meierhans Ruf SD, Meissner C et al (2015) orthotopic ileal bladder substitution in women: factors influencing urinary incontinence and hypercontinence. Eur Urol 68:664–671CrossRefPubMed

28.

Hautmann RE, Volkmer BG, Schumacher MC et al (2006) Long-term results of standard procedures in urology: the ileal neobladder. World J Urol 24:305–314CrossRefPubMed

29.

Elshal AM, Abol-Enein H, Mosbah A et al (2012) Serous-lined unidirectional valve for construction of continent cutaneous urinary reservoir: the test of time. Urology 80:452–458CrossRefPubMed

30.

Nazmy M, Yuh B, Kawachi M et al (2014) Early and late complications of robot-assisted radical cystectomy: a standardized analysis by urinary diversion type. J Urol 191:681–687CrossRefPubMed

31.

Ishioka J, Kageyama Y, Inoue M et al (2008) Prognostic model for predicting survival after palliative urinary diversion for ureteral obstruction: analysis of 140 cases. J Urol 180:618–621 (discussion 621) CrossRefPubMed

32.

Gilja I, Kovacic M, Radej M et al (1996) The sigmoidorectal pouch (Mainz pouch II). Eur Urol 29:210–215PubMed

33.

Gerharz EW, Kohl UN, Weingartner K et al (1998) Experience with the Mainz modification of ureterosigmoidostomy. Br J Surg 85:1512–1516CrossRefPubMed

34.

Hautmann RE, Abol-Enein H, Davidsson T et al (2013) ICUD–EAU International Consultation on Bladder Cancer 2012: urinary diversion. Eur Urol 63:67–80CrossRefPubMed

35.

Li K, Lin T, Fan X et al (2013) Systematic review and meta-analysis of comparative studies reporting early outcomes after robot-assisted radical cystectomy versus open radical cystectomy. Cancer Treat Rev 39:551–560CrossRefPubMed

36.

Leow JJ, Reese S, Trinh QD et al (2015) Impact of surgeon volume on the morbidity and costs of radical cystectomy in the USA: a contemporary population-based analysis. BJU Int 115:713–721CrossRefPubMed

37.

Wang YL, Jiang B, Yin FF et al (2015) Perioperative blood transfusion promotes worse outcomes of bladder cancer after radical cystectomy: a systematic review and meta-analysis. PLoS One 10:e0130122CrossRefPubMedPubMedCentral

38.

Abel EJ, Linder BJ, Bauman TM et al (2014) Perioperative blood transfusion and radical cystectomy: does timing of transfusion affect bladder cancer mortality? Eur Urol 66:1139–1147CrossRefPubMed

39.

Kretschmer A, Grimm T, Buchner A et al (2017) Prospective evaluation of health-related quality of life after radical cystectomy: focus on peri- and postoperative complications. World J Urol 35:1223–1231CrossRefPubMed

40.

Parekh DJ, Reis IM, Castle EP et al (2018) Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial. Lancet 391:2525–2536CrossRefPubMed

41.

Tyritzis SI, Hosseini A, Collins J et al (2013) Oncologic, functional, and complications outcomes of robot-assisted radical cystectomy with totally intracorporeal neobladder diversion. Eur Urol 64:734–741CrossRefPubMed

42.

Ahmed K, Khan SA, Hayn MH et al (2014) Analysis of intracorporeal compared with extracorporeal urinary diversion after robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium. Eur Urol 65:340–347CrossRefPubMed

43.

Izumi K, Mizokami A, Maeda Y et al (2011) Current outcome of patients with ureteral stents for the management of malignant ureteral obstruction. J Urol 185:556–561CrossRefPubMed

44.

Desgrandchamps F, Leroux S, Ravery V et al (2007) Subcutaneous pyelovesical bypass as replacement for standard percutaneous nephrostomy for palliative urinary diversion: prospective evaluation of patient’s quality of life. J Endourol 21:173–176CrossRefPubMed

45.

Shekarriz B, Shekarriz H, Upadhyay J et al (1999) Outcome of palliative urinary diversion in the treatment of advanced malignancies. Cancer 85:998–1003CrossRefPubMed

46.

Nix J, Smith A, Kurpad R et al (2010) Prospective randomized controlled trial of robotic versus open radical cystectomy for bladder cancer: perioperative and pathologic results. Eur Urol 57:196–201CrossRefPubMed

47.

Parekh DJ, Messer J, Fitzgerald J et al (2013) Perioperative outcomes and oncologic efficacy from a pilot prospective randomized clinical trial of open versus robotic assisted radical cystectomy. J Urol 189:474–479CrossRefPubMed

48.

Khan MS, Gan C, Ahmed K et al (2016) A single-centre early phase randomised controlled three-arm trial of open, robotic, and laparoscopic radical cystectomy (CORAL). Eur Urol 69:613–621CrossRefPubMed

49.

Richards KA, Kader AK, Otto R et al (2012) Is robot-assisted radical cystectomy justified in the elderly? A comparison of robotic versus open radical cystectomy for bladder cancer in elderly ≥ 75 years old. J Endourol 26:1301–1306CrossRefPubMed

50.

Knox ML, El-Galley R, Busby JE (2013) Robotic versus open radical cystectomy: identification of patients who benefit from the robotic approach. J Endourol 27:40–44CrossRefPubMed

51.

Bochner BH, Dalbagni G, Sjoberg DD et al (2015) Comparing open radical cystectomy and robot-assisted laparoscopic radical cystectomy: a randomized clinical trial. Eur Urol 67:1042–1050CrossRefPubMed

52.

Hu JC, Chughtai B, O’Malley P et al (2016) Perioperative outcomes, health care costs, and survival after robotic-assisted versus open radical cystectomy: a national comparative effectiveness study. Eur Urol 70:195–202CrossRefPubMed

Title: Update of the ICUD–SIU International Consultation on Bladder Cancer 2018: urinary diversion
Authors: Oscar Rodríguez Faba
Mark D. Tyson
Walter Artibani
Bernard H. Bochner
Fiona Burkhard
Scott M. Gilbert
Tilman Kälble
Stephan Madersbacher
Roland Seiler
Ella C. Skinner
George Thalmann
Joachim Thüroff
Peter Wiklund
Richard Hautmann
Joan Palou
Publication date: 01-01-2019
Publisher: Springer Berlin Heidelberg
Published in: World Journal of Urology / Issue 1/2019
Print ISSN: 0724-4983
Electronic ISSN: 1433-8726
DOI: https://doi.org/10.1007/s00345-018-2484-3

At a glance: The STEP trials

Springer Medicine

Update of the ICUD–SIU International Consultation on Bladder Cancer 2018: urinary diversion

Abstract

Purpose

Methods

Results

Conclusions

At a glance: The STEP trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2019

Intravesical BCG treatment causes a long-lasting reduction of recurrence and progression in patients with high-risk non-muscle-invasive bladder cancer

How bothersome double-J ureteral stents are after semirigid and flexible ureteroscopy: a prospective single-institution observational study

Wake-up call for more doctor–patient communication and an increase in public information campaigns on the risk factor of smoking with regard to the development and prognosis of bladder cancer

A new prognostic model for localized renal cell carcinoma

Epidemiology, biology and treatment of sarcomatoid RCC: current state of the art

ICUD-SIU International Consultation on Bladder Cancer 2017: management of non-muscle invasive bladder cancer